Project Grant HT94252410570
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The federal Project Grant award of $319,624 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Oregon Health & Science University (OHSU) located in Portland, Oregon. The award supports advanced biomedical research aimed at investigating cell cycle regulators in oligodendrocyte myelination, which is relevant to transforming healthcare for military service members and the broader public. OHSU, a prominent academic...
The federal Project Grant award, with ID HT94252510748, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, totaling $2,358,273.00, will support research at Oregon Health & Science University (OHSU) from September 1, 2025, through August 31, 2029. The research aims to investigate postural motor activation deficits following mild traumatic brain injury (mTBI), with the goal of translating laboratory findings into...
The federal Project Grant award of $391,743.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The award is for the development of a "compact, high resolution, 3D optical imager for anterior eye injury and disease." This research aims to advance innovative medical imaging technologies that can transform healthcare for military service members, veterans, and the...
The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
The U.S. Department of the Army Medical Command awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project will run from Sep...
The Oregon Health & Science University was awarded a $249,308 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2021 through March 31, 2024. The grant aims to support research titled "IANAM: THE ABILITY TO "VISUALIZE" HEADACHE, SLEEP DISTURBANCE, AND MTBI" which investigates medical solutions for conditions experienced by military service members, such as traumatic brain...
The U.S. Defense Health Agency has awarded a $623,953 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU) to conduct research on "Improved and Safer Chemotherapy of Medulloblastoma Using a Self-Assembled Nanomaterial." The award period runs from September 1, 2025, through August 31, 2027. This research project aims to develop innovative nanomaterial-based approaches to enhance the safety and efficacy...
This Project Grant award of $395,134.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), will fund a collaborative pilot project between Oregon Health & Science University (OHSU) and the Warm Springs Tribe to address health disparities in the Native American population. The project aims to transform healthcare for military service members and the broader public through innovative biomedical research focused...
Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Oregon Health & Science University (OHSU) was awarded a $644,570 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund the TBI Exosomal Activity in Military Personnel: Perivascular Space and Role of Indicators of Sleep Metrics (TEAM-PRISM) project. Through this funding, OHSU researchers will investigate medical solutions for traumatic brain injury on the battlefield by exploring the role...